Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK) | Zendy

Neil Woodford | Zendy; Li Xu-McCrae | Zendy; Shazad Mushtaq | Zendy; Houdini H.T. Wu | Zendy; Matthew J. Ellington | Zendy; Owen Lancaster | Zendy; Frances Davies | Zendy; Hugo Donaldson | Zendy; G. Gopal Rao | Zendy; Anita Verma | Zendy; David W. Wareham | Zendy; Holly Ciesielczuk | Zendy; Gregory G. Stone | Zendy; Paurus Irani | Zendy; Simon Bracher | Zendy; Peter M. Hawkey | Zendy

Open Access

Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK)

Author(s) -

Neil Woodford,

Li Xu-McCrae,

Shazad Mushtaq,

Houdini H.T. Wu,

Matthew J. Ellington,

Owen Lancaster,

Frances Davies,

Hugo Donaldson,

G. Gopal Rao,

Anita Verma,

David W. Wareham,

Holly Ciesielczuk,

Gregory G. Stone,

Paurus Irani,

Simon Bracher,

Peter M. Hawkey

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx471

Subject(s) - carbapenem , carbapenem resistant enterobacteriaceae , enterobacteriaceae , microbiology and biotechnology , enterobacteriaceae infections , urine , biology , medicine , antibiotics , escherichia coli , gene , biochemistry

Although carbapenem susceptibility testing has been recommended for all Enterobacteriaceae from clinical specimens, for practical reasons a carbapenem is not included in many primary antibiotic panels for urine specimens. The 'iCREST' study sought carbapenemase-producing Enterobacteriaceae (CPE) in routine urine specimens yielding Gram-negative growth in five diagnostic laboratories in the UK. We sought also to compare locally and centrally determined MICs of meropenem and ceftazidime/avibactam.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research